- Home
- FORR vs ACHV Comparison
FORR vs ACHV Comparison
Compare FORR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORR
- ACHV
- Stock Information
- Founded
- FORR 1983
- ACHV N/A
- Country
- FORR United States
- ACHV United States
- Employees
- FORR N/A
- ACHV N/A
- Industry
- FORR Diversified Commercial Services
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FORR Consumer Discretionary
- ACHV Health Care
- Exchange
- FORR Nasdaq
- ACHV Nasdaq
- Market Cap
- FORR 169.1M
- ACHV 167.6M
- IPO Year
- FORR 1996
- ACHV N/A
- Fundamental
- Price
- FORR $8.82
- ACHV $4.75
- Analyst Decision
- FORR
- ACHV Strong Buy
- Analyst Count
- FORR 0
- ACHV 1
- Target Price
- FORR N/A
- ACHV $12.00
- AVG Volume (30 Days)
- FORR 96.4K
- ACHV 2.4M
- Earning Date
- FORR 10-30-2025
- ACHV 11-07-2025
- Dividend Yield
- FORR N/A
- ACHV N/A
- EPS Growth
- FORR N/A
- ACHV N/A
- EPS
- FORR N/A
- ACHV N/A
- Revenue
- FORR $412,103,000.00
- ACHV N/A
- Revenue This Year
- FORR N/A
- ACHV N/A
- Revenue Next Year
- FORR $1.51
- ACHV N/A
- P/E Ratio
- FORR N/A
- ACHV N/A
- Revenue Growth
- FORR N/A
- ACHV N/A
- 52 Week Low
- FORR $8.45
- ACHV $1.84
- 52 Week High
- FORR $17.65
- ACHV $5.78
- Technical
- Relative Strength Index (RSI)
- FORR 42.36
- ACHV 68.79
- Support Level
- FORR $8.80
- ACHV $4.65
- Resistance Level
- FORR $9.39
- ACHV $5.07
- Average True Range (ATR)
- FORR 0.31
- ACHV 0.35
- MACD
- FORR 0.03
- ACHV 0.09
- Stochastic Oscillator
- FORR 30.24
- ACHV 64.69
About FORR Forrester Research Inc.
Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.